Geode Capital Management
SILO icon

Geode Capital Management’s Silo Pharma SILO Stock Holding History

Geode Capital Management’s Portfolio SILO Stock Details SILO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,002
Closed -$64.8K – 4551
2026
Q1 		$64.8K Buy
12,002
+5,808
+94% +$30K ﹤0.01% 4252
2025
Q4 		$31.6K Buy
6,194
+3,554
+135% +$26.3K ﹤0.01% 4319
2025
Q3 		$27.3K Buy
2,640
+20
+0.8% +$200 ﹤0.01% 4391
2025
Q2 		$24.8K Sell
2,620
-346
-12% -$3.96K ﹤0.01% 4335
2025
Q1 		$52K Buy
2,966
+636
+27% +$14.2K ﹤0.01% 4192
2024
Q4 		$31.1K Buy
2,330
+279
+14% +$4.32K ﹤0.01% 4320
2024
Q3 		$33.8K Buy
2,051
+972
+90% +$20.7K ﹤0.01% 4337
2024
Q2 		$15.7K Hold
1,079
– – ﹤0.01% 4491
2024
Q1 		$31.1K Hold
1,079
– – ﹤0.01% 4407
2023
Q4 		$23.3K Hold
1,079
– – ﹤0.01% 4487
2023
Q3 		$26.7K Sell
1,079
-557
-34% -$16.6K ﹤0.01% 4566
2023
Q2 		$49.8K Hold
1,636
– – ﹤0.01% 4507
2023
Q1 		$51.4K Buy
+1,636
New +$59.8K ﹤0.01% 4512

Other funds holding SILO

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Geode Capital Management's SILO Position: Q2 2026 in Review

Geode Capital Management sold out of Silo Pharma (SILO) in Q2 2026, closing a stake of 12,002 shares — an estimated $64.8K sold.

Geode Capital Management first reported a position in SILO in Q1 2023 and held it in 13 quarters. The position peaked at $64.8K in Q1 2026. 9 funds tracked by Wall St. Rank hold SILO as of Q2 2026.

  • Geode Capital Management reported no remaining Silo Pharma position as of Q2 2026 after selling out during the quarter.
  • Geode Capital Management sold 12,002 Silo Pharma shares in Q2 2026, an estimated $64.8K.
  • Geode Capital Management first reported a position in Silo Pharma in Q1 2023 and held it in 13 quarters.
  • Geode Capital Management's Silo Pharma position peaked at $64.8K in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Silo Pharma as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.